Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial.
Perez-Molina JA, Rubio R, Rivero A, Pasquau J, Suárez-Lozano I, Riera M, Estébanez M, Santos J, Sanz-Moreno J, Troya J, Mariño A, Antela A, Navarro J, Esteban H, Moreno S; GESIDA 7011 Study Group. Perez-Molina JA, et al. Lancet Infect Dis. 2015 Jul;15(7):775-84. doi: 10.1016/S1473-3099(15)00097-3. Epub 2015 Jun 7. Lancet Infect Dis. 2015. PMID: 26062881 Clinical Trial.
Neurocognitive safety after 96 weeks on dual therapy with atazanavir/ritonavir plus lamivudine: results of the neurocognitive substudy of the SALT randomized clinical trial.
Pérez-Valero I, Pasquau J, Rubio R, Rivero A, Santos J, Sanz J, Mariño A, Crespo M, Hernández-Quero J, Iribarren JA, Gutiérrez F, Terrón A, Esteban H, Pérez-Molina JA; GESIDA 7011 Study Group members. Pérez-Valero I, et al. J Antimicrob Chemother. 2018 Sep 1;73(9):2444-2451. doi: 10.1093/jac/dky212. J Antimicrob Chemother. 2018. PMID: 29897573 Free article. Clinical Trial.
Ankle-branch index and HIV: the role of antiretrovirals.
Olalla J, Salas D, Del Arco A, De la Torre J, Prada J, Machín-Hamalainen S, García-Alegría J. Olalla J, et al. HIV Med. 2009 Jan;10(1):1-5. doi: 10.1111/j.1468-1293.2008.00638.x. Epub 2008 Sep 14. HIV Med. 2009. PMID: 18795963 Free article.
[First antiretroviral therapy regimen in HIV-infected patients. Durability and factors associated with therapy changes].
de la Torre J, Santos J, Perea-Milla E, Pérez I, Moreno F, Palacios R, Santamaría S, Del Arco A, Nuño E, Godoy M, Prada JL, Olalla J, Aguilar J, Martos F; Grupo Malagueño de Enfermedades Infecciosa. de la Torre J, et al. Among authors: olalla j. Enferm Infecc Microbiol Clin. 2008 Aug-Sep;26(7):416-22. doi: 10.1157/13125638. Enferm Infecc Microbiol Clin. 2008. PMID: 18842236 Spanish.
Ankle-brachial index in HIV infection.
Olalla J, Salas D, de la Torre J, Del Arco A, Prada JL, Martos F, Perea-Milla E, García-Alegría J. Olalla J, et al. AIDS Res Ther. 2009 Apr 27;6:6. doi: 10.1186/1742-6405-6-6. AIDS Res Ther. 2009. PMID: 19397788 Free PMC article.
144 results